Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
David W. Bullock to Join Origin Agritech's Board of Directors 2014-11-04 19:00
Emery Oleochemicals Commercialises Production of RSPO Segregated Derivatives, Setting the Sustainability Tone in the Home and Personal Care Industry 2014-11-04 16:59
China Biologic to Build Two New Plasma Collection Stations in Hebei Province 2014-11-03 21:02
Hundreds Of Children In Afghanistan Receive Free Hearing Aids 2014-10-31 02:02
Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China 2014-10-30 23:25
China Biologic to Report Third Quarter 2014 Financial Results 2014-10-30 20:30
WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2014-10-30 20:00
Keeping it Real is the Focus of CD-adapco STAR-CCM+ v9.06 Release 2014-10-29 22:30
Shanghai Pharmaceuticals Achieves Rapid Business Growth for 3Q2014; Realized Double-Digit Growth of Revenue and Profit 2014-10-29 21:51
SAFC Launches New Protein Quality Supplement to Increase N-linked Glycosylation 2014-10-29 19:00
Leica Biosystems to Acquire Devicor Medical Products, Inc. 2014-10-28 23:13
OliPass Announces a Worldwide Discovery Alliance with Bristol-Myers Squibb for PNA-based Therapeutics 2014-10-28 20:50
AMRI to Announce Third Quarter Results on November 5, 2014 2014-10-24 20:00
WuXi Congratulates TaiMed Biologics on Receiving Orphan Drug Designation for Ibalizumab from U.S. FDA 2014-10-24 04:30
TPI's QLF Updates on its GMP Certification Progress 2014-10-23 20:34
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2014-10-22 21:50
Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT 2014-10-22 02:09
TWi Biotechnology Receives Orphan Drug Designation for its Lead Drug Candidate AC-201 in United States 2014-10-21 20:54
Sinovac to Participate in Jefferies 4th Annual Asia Summit 2014-10-21 18:06
Maxwell Biotech Portfolio Company Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta 2014-10-21 16:00
1 177 178 179 180 181 222